Majmudar Parag A, Epstein Randy J, Parent Alan, Raphtis E Mike, Grostern Richard, Torczynski Elise
Department of Ophthalmology, Rush University Medical Center, Chicago, IL, USA.
Cornea. 2006 Jul;25(6):727-33. doi: 10.1097/01.ico.0000224637.57062.d9.
To describe a noninvasive technique that can be used to support a clinically suspected diagnosis of epithelial downgrowth in patients who have previously undergone penetrating keratoplasty (PK).
Previously resected corneal buttons of 14 patients who developed signs suggestive of epithelial downgrowth after PK were examined retrospectively using immunohistochemical analysis to determine if occult epithelial cells were in fact present on the posterior surface of the cornea. Many of these patients were diagnosed with pseudophakic corneal edema or graft failure and had undergone multiple intraocular surgical procedures. In all cases, the initial histopathologic evaluation did not disclose the presence of epithelial cells using light microscopy after standard handling and staining techniques. Fourteen age- and diagnosis-matched control specimens were also examined.
Thirteen of 14 specimens (92.9%) exhibited positive staining with anti-keratin AE1/AE3 markers, indicating that epithelial cells were already present on the endothelial surface at the time of the original PK. None of the control specimens displayed positive staining of the retrocorneal surface.
Retrospective immunohistochemical analysis of corneal specimens can establish the diagnosis of epithelial downgrowth in a noninvasive manner. Early diagnosis may allow for this condition to be treated more successfully if aggressive intervention is undertaken. Alternatively, it may spare the patient from additional (and potentially futile) intraocular surgery. In the clinical setting of suspected epithelial downgrowth, ophthalmic pathologists should re-evaluate PK specimens from patients initially diagnosed with pseudophakic corneal edema or graft failure.
描述一种非侵入性技术,可用于辅助临床上对曾接受穿透性角膜移植术(PK)的患者上皮植入的疑似诊断。
对14例PK术后出现上皮植入迹象的患者的既往切除角膜植片进行回顾性检查,采用免疫组织化学分析确定角膜后表面是否实际存在隐匿性上皮细胞。这些患者中许多被诊断为人工晶状体性角膜水肿或移植失败,并接受了多次眼内手术。在所有病例中,按照标准处理和染色技术,初始组织病理学评估在光学显微镜下未发现上皮细胞的存在。还检查了14个年龄和诊断匹配的对照标本。
14个标本中有13个(92.9%)用抗角蛋白AE1/AE3标记物呈阳性染色,表明在初次PK时内皮表面就已存在上皮细胞。对照标本的角膜后表面均未显示阳性染色。
对角膜标本进行回顾性免疫组织化学分析可以以非侵入性方式确诊上皮植入。如果采取积极干预措施,早期诊断可能使这种情况得到更成功的治疗。或者,它可以使患者避免额外的(且可能无效的)眼内手术。在疑似上皮植入的临床情况下,眼科病理学家应重新评估最初诊断为人工晶状体性角膜水肿或移植失败患者的PK标本。